XOMA to Present at the 42nd Annual Cowen Health Care Conference

12:30pm, Tuesday, 01'st Mar 2022 GlobeNewswire Inc.
EMERYVILLE, Calif., March 01, 2022 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator playing a distinctive role in helping companies achieve their goal of impro
EMERYVILLE, Calif., March 01, 2022 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator playing a distinctive role in helping companies achieve their goal of improvi

XOMA (XOMA) Investor Presentation - Slideshow

05:30pm, Sunday, 27'th Feb 2022 Seeking Alpha

XOMA to Present at Aegis Capital Corp Investor Conference

12:30pm, Thursday, 17'th Feb 2022 GlobeNewswire Inc.
EMERYVILLE, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator playing a distinctive role in helping companies achieve their goal of improv
EMERYVILLE, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator playing a distinctive role in helping companies achieve their goal of improvin

XOMA Declares Quarterly Preferred Stock Dividends

12:30pm, Thursday, 23'rd Dec 2021 GlobeNewswire Inc.
EMERYVILLE, Calif., Dec. 23, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following cash divid

XOMA Declares Quarterly Preferred Stock Dividends

12:30pm, Thursday, 23'rd Dec 2021 GlobeNewswire
EMERYVILLE, Calif., Dec. 23, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (XOMA or the Company) today announced its Board of Directors has authorized the following cash dividends to holders of XOMAs Series A and Series B Cumulative Preferred Stock:

XOMA to Present at Upcoming Investor Conferences

12:30pm, Tuesday, 21'st Dec 2021 GlobeNewswire Inc.
EMERYVILLE, Calif., Dec. 21, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator playing a distinctive role in helping companies achieve their goal of improv
EMERYVILLE, Calif., Dec. 21, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator playing a distinctive role in helping companies achieve their goal of improvin

XOMA CEO Jim Neal to retire

02:20pm, Thursday, 16'th Dec 2021 Seeking Alpha

XOMA Announces Evolution of Company Leadership and Succession Planning

12:30pm, Thursday, 16'th Dec 2021 GlobeNewswire Inc.
Chief Executive Officer Jim Neal appointed as Chairman; Former Chairman W. Denman Van Ness to remain Lead Independent Director

XOMA Announces Evolution of Company Leadership and Succession Planning

12:30pm, Thursday, 16'th Dec 2021 Intrado Digital Media
Chief Executive Officer Jim Neal appointed as Chairman; Former Chairman W. Denman Van Ness to remain Lead Independent Director

XOMA Co. (NASDAQ:XOMA) Stock Position Raised by State Street Corp

11:50am, Tuesday, 30'th Nov 2021 Transcript Daily
State Street Corp lifted its stake in XOMA Co. (NASDAQ:XOMA) by 13.7% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 120,424 shares of the biotechnology companys stock after acquiring an additional 14,475 shares during the period. State Street Corp owned 1.06% of XOMA worth $4,094,000 []
Another exploration Titled "Worldwide Botulinum 2019-Market Research Report" gives the Professional and inside and out assessment of extent of momentum and future market and survey of Product Specification, showcase pattern , item type and creation investigation considering central point, for
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE